Vanguard Group Inc

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 9.38M shares
Security Ownership: 5.95%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.38M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 5.95% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	5.95%		$23.4M	9.38M			$2.50	13G/A	6/30/2025	29 Jul 2025 11:22:08

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$21.3M	9.38M	+4,262,418	+83.3%	$2.27	Q2 2025
3/31/2025	0%	0%	$3.25M	5.12M	-44,926		$0.64	Q1 2025
12/31/2024	0%		$5.32M	5.16M			$1.03	Q4 2024
9/30/2024	0%	+0%	$6.09M	5.16M	+270,000	+5.52%	$1.18	Q3 2024
6/30/2024	0%	+0%	$5.97M	4.89M	+34,928	+0.72%	$1.22	Q2 2024
3/31/2024	0%	0%	$10.6M	4.86M	-45,569	-0.93%	$2.18	Q1 2024
12/31/2023	0%		$7.6M	4.9M			$1.55	Q4 2023
9/30/2023	0%		$6.32M	4.9M			$1.29	Q3 2023
6/30/2023	0%		$8.43M	4.9M	-12,110	-0.25%	$1.72	Q2 2023
3/31/2023	0%	+0%	$7.42M	4.92M	+329,332	+7.18%	$1.51	Q1 2023
12/31/2022	0%	+0%	$7.34M	4.59M	+47,760	+1.05%	$1.60	Q4 2022
9/30/2022	0%	0%	$6.58M	4.54M	-540,426	-10.6%	$1.45	Q3 2022
6/30/2022	0%	0%	$9.29M	5.08M	-144,499	-2.77%	$1.83	Q2 2022
3/31/2022	0%	+0%	$13.9M	5.22M	+114,895	+2.25%	$2.67	Q1 2022
12/31/2021	0%	0%	$22.1M	5.11M	-408,330	-7.4%	$4.33	Q4 2021
9/30/2021	0%	+0%	$28.1M	5.52M	+158,236	+2.95%	$5.09	Q3 2021
6/30/2021	0%	+0%	$33.9M	5.36M	+697,287	+15%	$6.33	Q2 2021
3/31/2021	0%	+0%	$36M	4.66M	+1,726,374	+58.8%	$7.73	Q1 2021
12/31/2020	0%	+0%	$19.2M	2.93M	+80,236	+2.81%	$6.55	Q4 2020
9/30/2020	0%	+0%	$19M	2.85M	+201,853	+7.61%	$6.65	Q3 2020
6/30/2020	0%	0%	$22.1M	2.65M	-58,204	-2.15%	$8.33	Q2 2020
3/31/2020	0%	+0%	$20.8M	2.71M	+20,935	+0.78%	$7.67	Q1 2020
12/31/2019	0%	+0%	$22.4M	2.69M	+80,106	+3.07%	$8.31	Q4 2019
9/30/2019	0%	0%	$19.3M	2.61M	-61,876	-2.32%	$7.38	Q3 2019
6/30/2019	0%	+0%	$30M	2.67M	+259,355	+10.8%	$11.22	Q2 2019
3/31/2019	0%	+0%	$25.9M	2.41M	+956,095	+65.7%	$10.75	Q1 2019
12/31/2018	0%	0%	$22M	1.46M	-1,049,063	-41.9%	$15.10	Q4 2018
9/30/2018	0%	+0%	$46.3M	2.5M	+387,722	+18.3%	$18.50	Q3 2018
6/30/2018	0%	+0%	$48.4M	2.12M	+653,382	+44.6%	$22.86	Q2 2018
3/31/2018	0%	+0%	$41.6M	1.46M	+262,772	+21.9%	$28.45	Q1 2018
12/31/2017	0%	+0%	$25.4M	1.2M	+52,905	+4.61%	$21.11	Q4 2017
9/30/2017	0%	+0%	$20.9M	1.15M	+224,068	+24.2%	$18.17	Q3 2017
6/30/2017	0%	+0%	$14.3M	924K	+100,607	+12.2%	$15.50	Q2 2017
3/31/2017	0%	+0%	$14.2M	824K	+27,532	+3.46%	$17.27	Q1 2017
12/31/2016	0%	+0%	$8.75M	796K	+11,353	+1.45%	$10.99	Q4 2016
9/30/2016	0%	+0%	$12.3M	785K	+413,124	+111%	$15.68	Q3 2016
6/30/2016	0%	+0%	$3.8M	372K	+141,466	+61.5%	$10.21	Q2 2016
3/31/2016	0%	+0%	$2.97M	230K	+30,919	+15.5%	$12.90	Q1 2016
12/31/2015	0%	+0%	$4.16M	199K	+199,137	NEW	$20.87	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.